Literature DB >> 9430193

Linking outcomes management to quality-of-life measurement.

D Cella1, K Webster.   

Abstract

Health-care workers now accept quality of life (QOL) as an important outcome to evaluate in clinical research and as a useful measure of quality care. Indeed, current demand for QOL assessment in clinical practice has outpaced the availability of valid, streamlined, cost-effective methods for carrying out such assessment, although new tools are in the offing. This paper will highlight some of the major challenges facing outcomes management and outcomes research, with particular focus on the development of a QOL instrument to evaluate and manage anemia and fatigue in cancer patients--the Functional Assessment of Cancer Therapy-Anemia (FACT-An). The newest version of broader QOL assessment system, the Functional Assessment of Chronic Illness Therapy (FACIT), will also be described.

Entities:  

Mesh:

Year:  1997        PMID: 9430193

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  12 in total

Review 1.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

2.  A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.

Authors:  Constantinos E Alifieris; Kyriakos Orfanakos; Aristina Papanota; George P Stathopoulos; Nikolaos Sitaras; Dimitrios T Trafalis
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-11       Impact factor: 4.553

3.  Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report.

Authors:  Ilya Laufer; Simon S Lo; Eric L Chang; Jason Sheehan; Matthias Guckenberger; Moon-Jun Sohn; Samuel Ryu; Matthew Foote; Alexander Muacevic; Scott G Soltys; Samuel Chao; Sten Myrehaug; Peter C Gerszten; Eric Lis; Pejman Maralani; Mark Bilsky; Charles Fisher; Laurence Rhines; Jorrit-Jan Verlaan; David Schiff; Michael G Fehlings; Lijun Ma; Susan Chang; Wendy R Parulekar; Michael A Vogelbaum; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

4.  Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events.

Authors:  Christine B Boers-Doets; Hans Gelderblom; Mario E Lacouture; Joel B Epstein; Johan W R Nortier; Ad A Kaptein
Journal:  Support Care Cancer       Date:  2013-02-17       Impact factor: 3.603

5.  Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses.

Authors:  Barbara A Elliott; Colleen M Renier; Irina V Haller; Thomas E Elliott
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 6.  Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.

Authors:  Amy P Abernethy; Jane L Wheeler; S Yousuf Zafar
Journal:  Curr Opin Support Palliat Care       Date:  2010-03       Impact factor: 2.302

Review 7.  Cancer-related fatigue: role of oncology nurses in translating National Comprehensive Cancer Network assessment guidelines into practice.

Authors:  Barbara F Piper; Tami Borneman; Virginia Chih-Yi Sun; Marianna Koczywas; Gwen Uman; Betty Ferrell; Raysenia L James
Journal:  Clin J Oncol Nurs       Date:  2008-10       Impact factor: 1.027

Review 8.  Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety.

Authors:  Lívia Lovato Pires Lemos; Juliana de Oliveira Costa; Alessandra Maciel Almeida; Haliton Oliveira Junior; Mariana Michel Barbosa; Adriana Maria Kakehasi; Francisco Assis Acurcio
Journal:  Rheumatol Int       Date:  2014-04-13       Impact factor: 2.631

9.  The level of haemoglobin in anaemic cancer patients correlates positively with quality of life.

Authors:  M Lind; C Vernon; D Cruickshank; P Wilkinson; T Littlewood; N Stuart; C Jenkinson; P Grey-Amante; H Doll; D Wild
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

10.  Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis.

Authors:  Elizabeth D Bacci; Amy M DeLozier; Chen-Yen Lin; Carol L Gaich; Xiang Zhang; Terence Rooney; Stephanie de Bono; Richard Hoffman; Kathleen W Wyrwich
Journal:  Health Qual Life Outcomes       Date:  2017-12-06       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.